Caredx Inc sell nvestor
Summary
This prediction ended on 16.09.23 with a price of €7.35. The prediction for Caredx Inc closed with a convincing performance of -13.49%. nvestor has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Caredx Inc | 3.236% | 3.236% | 190.337% |
iShares Core DAX® | 2.821% | -1.953% | 15.071% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% |
Comments by nvestor for this prediction
In the thread Caredx Inc diskutieren
In the thread Trading Caredx Inc